Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease

OSUWexnerbloglogo2014 On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease. We have come a long way since Crohn, Ginzburg, and Oppenheimer first described inflammatory bowel disease. On this CME Webcast, we’re going to bring you up to date on Crohn’s disease and ulcerative colitis, what they are, how to diagnose them and new treatments for inflammatory bowel disease. We’re pleased to have the Medical Director of the OSU Inflammatory Bowel Disease Center, gastroenterologist and Assistant Professor of Internal Medicine, Dr. Anita Afzali joining us on the program.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the role of the primary care provider (PCP) in IBD; and DEVELOP a health maintenance plan for the patient with IBD.

You’ll also learn about the following:

  • Etiology of inflammatory bowel disease
  • New developments in treatment of inflammatory bowel disease
  • Diet and inflammatory bowel disease
  • Pregnancy and inflammatory bowel disease
  • Management of small bowel obstruction and acute exacerbations of pain
  • Duration of biologic therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.